Sera Prognostics, Inc. SEC filings SERA

Sera Prognostics, Inc. has 660 filings in SEC EDGAR's recent list, going back to Nov 21, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
424B5 Prospectus supplement Mar 18, 2026 —
S-8 Employee stock plan registration Mar 18, 2026 —
S-8 Employee stock plan registration Mar 19, 2025 —
424B5 Prospectus supplement Feb 11, 2025 —
424B5 Prospectus supplement Feb 10, 2025 —
424B5 Prospectus supplement Aug 13, 2024 —
S-3 Shelf registration Aug 7, 2024 —
S-8 Employee stock plan registration Mar 20, 2024 —
S-8 Employee stock plan registration Mar 22, 2023 —
S-8 Employee stock plan registration Mar 29, 2022 —
S-8 Employee stock plan registration Aug 11, 2021 —
424B4 Prospectus Jul 16, 2021 —
S-1/A Amended registration statement Jul 8, 2021 —
S-1 Registration statement Jun 11, 2021 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
SERA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1534969
Former names
SERA PROGNOSTICS, INC. (until Nov 4, 2026)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.